Kaplan-Meier survival curve. For the analysis has been considered the age of onset for AD patients and the age of conversion for the MCI-AD. The number of subjects at risk respectively at: the 25% percentile, median, and 75% percentile of Median time for each group are reported. The test showed that patients with higher serum levels of BACE1 (of the median (16.67 kU/L): BACE > 50) anticipate the pathology of 8 years (77 > 69, p = 0.008, Breslow test, BACE < = 50 group: Median time = 77; 25% Percentile = 73.56; 75% Percentile = 80.44; BACE > 50 group: Median time = 69; 25% Percentile = 65.28; 75% Percentile = 72.71).